Literature DB >> 9018027

Cerebral oxygen metabolism in patients with progressive supranuclear palsy: a positron emission tomography study.

P Santens1, J De Reuck, L Crevits, D Decoo, I Lemahieu, K Strijckmans, P Goethals.   

Abstract

To investigate cerebral oxygen metabolism in progressive supranuclear palsy (PSP), 5 patients with a clinical diagnosis of PSP and a variable degree of cognitive deficit were selected for positron emission tomography (PET) of the brain. In 4 of them, a significant decrease in oxygen metabolism was found in all cortical regions, without frontal accentuation. In the group as a whole, this decrease was even slightly more marked in parietal and temporal regions. These findings are not consistent with earlier PET studies that demonstrated frontal targeting of hypometabolism in PSP patients. Part of this discrepancy can be explained by differences in methodology, although the use of different clinical criteria and overlap of PSP with other neurodegenerative diseases must be taken into account. It is concluded that the absence of frontal hypometabolism on PET examination does not exclude the diagnosis of PSP.

Entities:  

Mesh:

Year:  1997        PMID: 9018027     DOI: 10.1159/000117398

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  5 in total

1.  MRI estimation of global brain oxygen consumption rate.

Authors:  Varsha Jain; Michael C Langham; Felix W Wehrli
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-21       Impact factor: 6.200

2.  Separation of cellular and BOLD contributions to T2* signal relaxation.

Authors:  Xialing Ulrich; Dmitriy A Yablonskiy
Journal:  Magn Reson Med       Date:  2015-03-10       Impact factor: 4.668

Review 3.  Mitochondrial dysfunction as a therapeutic target in progressive supranuclear palsy.

Authors:  Vincent Ries; Wolfgang H Oertel; Günter U Höglinger
Journal:  J Mol Neurosci       Date:  2011-07-27       Impact factor: 3.444

Review 4.  Blood oxygenation level-dependent (BOLD)-based techniques for the quantification of brain hemodynamic and metabolic properties - theoretical models and experimental approaches.

Authors:  Dmitriy A Yablonskiy; Alexander L Sukstanskii; Xiang He
Journal:  NMR Biomed       Date:  2012-08-28       Impact factor: 4.044

5.  Assessing the repeatability of absolute CMRO2, OEF and haemodynamic measurements from calibrated fMRI.

Authors:  Alberto Merola; Michael A Germuska; Kevin Murphy; Richard G Wise
Journal:  Neuroimage       Date:  2018-02-14       Impact factor: 6.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.